MEDULLOBLASTOMA, A NEW DRUG, CT-179, CAN TARGET CANCER STEM CELLS

MEDULLOBLASTOMA, A NEW DRUG, CT-179, CAN TARGET CANCER STEM CELLS Brain cancer remains the leading cause of cancer-related death in children. Medulloblastoma (MB) is the most common pediatric brain cancer and accounts for approximately 20% of all cases. Dr. Tim Gershon, a pediatric neurologist at Children’s Healthcare of Atlanta and his team are working on […]